| |
| |
|
| Insider
Information: |
Krognes Steve E. |
| Relationship: |
Director |
| City: |
Burlingame |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
50,734 |
|
|
Indirect Shares
|
850,000 |
|
|
| Direct
Value |
$866,814 |
|
|
|
Indirect Value
|
$15,563,500 |
|
|
| Total
Shares |
900,734 |
|
|
| Total
Value |
$16,430,314 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
14
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
12
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 21.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Denali Therapeutics Inc. |
DNLI |
Director |
2024-04-01 |
47,341 |
2024-04-01 |
850,000 |
Premium* |
|
|
Guardant Health, Inc. |
GH |
Director |
2024-04-30 |
3,393 |
2023-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GH |
Guardant Health, Inc. |
Director |
– • – |
2024-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
3,393 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2024-04-01 |
4 |
AS |
$20.50 |
$1,896,250 |
D/D |
(92,500) |
47,341 |
0 |
% |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2024-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
3,239 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2024-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
3,085 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2024-02-13 |
4 |
S |
$17.29 |
$47,548 |
D/D |
(2,750) |
139,841 |
0 |
% |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2024-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
155 |
2,931 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2024-01-05 |
4 |
S |
$19.43 |
$62,331 |
D/D |
(3,208) |
142,591 |
0 |
% |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
2,776 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2023-11-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
2,622 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2023-10-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
2,468 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2023-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
155 |
2,314 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2023-08-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
2,159 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2023-08-21 |
4 |
S |
$22.60 |
$32,069 |
D/D |
(1,419) |
145,799 |
0 |
% |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2023-07-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
2,005 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2023-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,851 |
1,851 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,216 |
147,218 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2023-02-13 |
4 |
S |
$30.10 |
$63,782 |
D/D |
(2,119) |
143,002 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2023-02-08 |
4 |
S |
$30.88 |
$42,522 |
D/D |
(1,377) |
145,121 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2023-01-05 |
4 |
S |
$28.44 |
$84,467 |
D/D |
(2,970) |
146,498 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2022-08-19 |
4 |
S |
$33.22 |
$74,845 |
D/D |
(2,253) |
149,468 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2022-07-19 |
4 |
OE |
$0.68 |
$42,500 |
D/D |
62,500 |
151,721 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
CFO and Treasurer |
• – – |
2022-02-11 |
4 |
S |
$34.69 |
$88,806 |
D/D |
(2,560) |
120,221 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
CFO and Treasurer |
• – – |
2022-02-09 |
4 |
S |
$37.09 |
$48,073 |
D/D |
(1,296) |
122,781 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
CFO and Treasurer |
• – – |
2022-01-05 |
4 |
S |
$44.75 |
$99,569 |
D/D |
(2,225) |
124,077 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
CFO and Treasurer |
• – – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
31,000 |
126,302 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
